NEMA NU 1-2018 performance characterization and Monte Carlo model validation of the Cubresa Spark SiPM-based preclinical SPECT scanner

por Strugari, Matthew E., DeBay, Drew R., Beyea, Steven D., Brewer, Kimberly D.
Publicado 2023

No difference in cerebral perfusion between the wild-type and the 5XFAD mouse model of Alzheimer’s disease

por DeBay, Drew R., Phi, Tân-Trào, Bowen, Chris V., Burrell, Steven C., Darvesh, Sultan
Publicado 2022

Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease

por DeBay, Drew R., Reid, George A., Pottie, Ian R., Martin, Earl, Bowen, Chris V., Darvesh, Sultan
Publicado 2017

Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer’s Disease

por Macdonald, Ian R., Maxwell, Selena P., Reid, George A., Cash, Meghan K., DeBay, Drew R., Darvesh, Sultan
Publicado 2017

Using MRI to evaluate and predict therapeutic success from depot-based cancer vaccines

por DeBay, Drew R, Brewer, Kimberly D, LeBlanc, Sarah A, Weir, Genevieve M, Stanford, Marianne M, Mansour, Marc, Bowen, Chris V
Publicado 2015

Using lymph node swelling as a potential biomarker for successful vaccination

por Brewer, Kimberly D., DeBay, Drew R., Dude, Iulia, Davis, Christa, Lake, Kerry, Parsons, Cathryn, Rajagopalan, Rajkannan, Weir, Genevieve, Stanford, Marianne M., Mansour, Marc, Bowen, Chris V.
Publicado 2016